CYLD and neoplasm: It promotes tumor cell survival, proliferation, and invasion via EGFR-induced NF-κB activation, while its scaffolding and protease activities regulate key signaling pathways, including the inactivation of NF-κB pathway inhibitors, specifically A20 and CYLD [45,46].